04 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2025/03/04/3036397/0/en/Protega-Pharmaceuticals-collaborates-with-Wellgistics-to-support-pharmacist-education-and-increase-patient-access-to-the-first-and-only-FDA-approved-abuse-deterrent-immediate-relea.html
03 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/protega-pharmaceuticals-collaborates-with-wellgistics-health-to-support-pharmacist-education-and-increase-patient-access-to-the-first-and-only-fda-approved-abuse-deterrent-immediate-release-opioid-roxybond-302389618.html
28 Jan 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/tris-builds-clinical-case-opioid-alternative-showing-pain-drug-less-likely-be-abused
21 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/21/3012506/0/en/Scilex-Holding-Company-Announces-that-It-Will-Be-Filing-Today-of-a-Supplemental-New-Drug-Application-with-the-FDA-for-ELYXYB-in-Acute-Pain-Indication.html
29 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/protega-pharmaceuticals-receives-fda-approval-for-roxybond-oxycodone-hydrochloride-immediate-release-10-mg-tablet-with-abuse-deterrent-technology-for-management-of-pain-302289975.html
15 Nov 2023
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-15-2023-17266.pdf